Anixa Biosciences Inc Income Statement
ANIX|12 years of annual SEC 10-K data (FY2011-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
Anixa Biosciences Inc reported $210,000 in revenue and $13M in net loss for FY2024. Revenue has declined at a 9.1% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $210.0K | $210.0K | $512.0K | $250.0K | $1.1M | $362.5K | $300.0K | $9.3M | $3.7M | $388.9K | $1.0M | $730.7K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | $34.1K | $82.3K |
| SG&A Expense | $7.4M | $7.2M | $7.1M | $5.7M | $6.9M | $4.4M | $2.7M | $5.5M | $6.4M | $8.0M | $2.9M | $2.9M |
| R&D Expense | $6.4M | $6.7M | $6.2M | $5.5M | $6.8M | $1.6M | $1.6M | $711.4K | - | - | $3.1M | $3.0M |
| Operating Income | -$13.8M | -$13.9M | -$13.1M | -$11.9M | -$14.3M | -$6.1M | -$4.5M | -$944.8K | -$5.0M | -$7.9M | -$5.0M | -$5.2M |
| Interest Expense | - | - | - | - | - | $500.5K | $519.9K | $451.9K | $1.3M | $1.1M | $7.7K | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - | $600.0K | $600.0K |
| Net Income | -$12.6M | -$13.6M | -$13.0M | -$11.6M | -$14.2M | -$5.0M | -$5.0M | -$1.4M | -$9.6M | -$10.1M | -$7.4M | -$5.2M |
| EPS (Basic) | -$0.32 | $0.45 | -$0.45 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.32 | $0.45 | -$0.45 | -$0.59 | -$0.79 | -$0.58 | -$0.57 | -$16.00 | -$1.10 | -$0.05 | -$0.04 | -$0.03 |
| Shares Outstanding | 31.1M | 30.9M | 30.1M | 20.3M | 18.9M | 16.6M | 8.8M | 8.7M | 8.8M | 209.3M | 176.1M | 153.7M |
| Operating Margin | -6586.2% | -6607.1% | -2565.6% | -4756.0% | -1284.4% | -1676.0% | -1503.0% | -10.2% | -137.5% | -2036.2% | -501.2% | -718.3% |
| Profit Margin | -5978.1% | -6473.8% | -2530.1% | -4658.8% | -1280.3% | -1381.8% | -1672.1% | -14.9% | -261.9% | -2592.3% | -735.5% | -708.3% |